Boston University, Massachusetts; Higher Education, Private Coll/Univ - General Obligation Jun 02

  • ID: 1869440
  • June 2002
  • Region: Massachusetts
  • Standard & Poors
1 of 3

The 'BBB+' rating on the outstanding debt issued for Boston University reflects: Large, comprehensive academic programs; Good demand, which has become more competitive, particularly on the undergraduate level, since 1992; and A long history of solid financial operations. Offsetting factors include: Low levels of unrestricted resources relative to operating expenses and debt; Increased leverage; and Endowment-market-value declines. The university is issuing $250 million of series 2002 bonds to construct an arena, a sports/recreational center, a parking garage, and a track/tennis facility ($240 million) and refund the university's outstanding series M bonds ($10.7 million). The bonds will be insured, and liquidity will be provided by standby bond-purchase agreements. The outlook reflects expectations that healthy financial operations will continue and that Boston...

Companies mentioned in this report are:
- Boston Univ
- Massachusetts Development Finance Agency

Action: New Rating

Standard and Poors RatingsXpress Credit Research provides in-depth coverage of international corporates, financial institutions, insurance companies, utilities, sovereigns and structured finance programs. RatingsXpress Credit Research lets users determine the credit rating of holdings and identify key factors underlying an issuer's creditworthiness, distinguishes the different risk exposures for new and existing deals, and provides an understanding of how their analysts interpret key regulatory, political and environmental events and their economic impact.

Research Type: Full Analysis

Note: Product cover images may vary from those shown
2 of 3

- Boston Univ
- Massachusetts Development Finance Agency

Note: Product cover images may vary from those shown
3 of 3
Note: Product cover images may vary from those shown


  • Quick Help: This Credit Rating Report will be emailed to you.


If you have a more general question about our products please try our



Our Clients

  • Fluidigm Corporation
  • Apple, Inc.
  • CEVA Santé Animale
  • Abbott Laboratories Ltd.
  • Merck Group
  • Allergan Inc.
  • Pfizer Inc.